Impact of a behaviorally-based weight loss intervention on parameters of insulin resistance in breast cancer survivors

Table 1 Baseline characteristics of participants by weight loss category

	< 5% (n = 20)	≥ 5% (n = 31)	P
Age, years (M ± SD)	54.25 ± 4.78	54.29 ± 6.55	0.757
Age range (years)	47-64	39-65
Time from diagnosis (mos.) (M ± SD)	37.45 ± 19.27	31.65 ± 20.13	0.210
Range of time from Diagnosis (mos.)	10-83	9-110
Stage
0	2 (10%)	1 (3%)
I	7 (35%)	21 (68%)	0.042
II	5 (25%)	7 (23%)
III	6 (30%)	2 (6%)
Receipt of Chemotherapy	15 (75%)	19 (61%)	0.373
Receipt of Radiation	17 (85%)	26 (84%)	1.000
Use of Endocrine Therapy	15 (75%)	27 (87%)	0.289
BMI at diagnosis (kg/m2) (M ± SD)	33.41 ± 7.55	31.05 ± 5.37	0.349
BMI at study initiation (kg/m2) (M ± SD)	34.48 ± 7.71	32.20 ± 4.63	0.531
Physical Activity Duration^a (min/week) at study initiation (M ± SD)	60.00 ± 49.72	67.10 ± 35.32	0.329
Diagnosis of pre-diabetes and diabetes based on baseline glucose values
Pre-diabetes	17 (85%)	18 (58%)
Diabetes	0 (0%)	1 (3%)	0.088
Diabetes	85%	61%

Categorical variables were tested using Fisher’s Exact Test. Continuous variables were tested using the Wilcoxon Rank Sum Test
^aPhysical activity performed at a moderate or greater intensity (≥ 3 METS)

ISSN: 1471-2407